Melius Pharma logo

Melius Pharma

Clinical stage biopharma company developing treatments for diseases with high unmet needs at a reduced development risk

3 employees · est. 2021 · Sweden

VS
Trevi Therapeutics, Inc. logo

Trevi Therapeutics, Inc.

Clinical-stage biopharmaceutical company

34 employees · est. 2011 · New Haven, United States

Trevi Therapeutics, Inc. is the older company (2021 vs 2011); Trevi Therapeutics, Inc. is the larger of the two.

Side-by-Side Comparison

Melius Pharma Trevi Therapeutics, Inc.
Founded
2021 2011 older
Headquarters
Sweden New Haven, United States
Employees
3 34 larger
Industry
Health Care, Pharmaceutical Biotechnology, Health Care, Pharmaceutical
Funding Stage
Series A Post Ipo Equity
Total Funding
$18.00M $156.53M
Funding Rounds
1 7
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Clinical Stage Biopharma, Drug Development, Treatment Development, Chronic Cough, Pulmonary Fibrosis, Clinical Trial, Exploratory Data, New Chemical Entity, Interstitial Lung Diseases, Pharmaceutical Company, ME-015, Suplatast Tosilate, Oral Treatment, High Unmet Clinical Needs Not tracked yet
Website
meliuspharma.com trevitherapeutics.com
Melius Pharma logo

About Melius Pharma

Melius Pharma: A Swedish clinical stage pharmaceutical company, is focused on developing treatments for severe diseases with high unmet clinical needs at a reduced development risk. The company's flagship product, ME-015 (suplatast tosilate), is a first-in-class, safe, and well-tolerated oral treatm...

Trevi Therapeutics, Inc. logo

About Trevi Therapeutics, Inc.

Trevi Therapeutics is a biotechnology startup founded in 2011. It operates in the healthcare and pharmaceutical industries. Their latest investment of $55.00M in Post-IPO Equity was secured on April 07, 2022. The investment came from a group of prominent investors including New Enterprise Associates...

We will tell you when either one moves

BounceWatch watches Melius Pharma and Trevi Therapeutics, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Melius Pharma and Trevi Therapeutics, In... — by email.

Frequently Asked Questions

Melius Pharma — Clinical stage biopharma company developing treatments for diseases with high unmet needs at a reduced development risk. Trevi Therapeutics, Inc. — Clinical-stage biopharmaceutical company. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Melius Pharma has raised $18.00M while Trevi Therapeutics, Inc. has raised $156.53M.
Melius Pharma and Trevi Therapeutics, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Melius Pharma with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Melius Pharma on 12 Sep 2024, and Trevi Therapeutics, Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy